Financing
Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky
Piramal Pharma Ltd.
PR-09-24-NI-24Sep 30, 2024
In Vitro Biology
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
Piramal Pharma Solutions
PR-M10-23-04Oct 17, 2023
New Facility
Piramal Pharma Solutions Holds Grand Opening Ceremony for New API Plant at Aurora, Canada Manufacturing Site
Piramal Pharma Solutions
PR-M07-22-04Jul 13, 2022
Business Leadership
Piramal Pharma Ltd Strengthens Board by Inducting Three New Board Members
Piramal Pharma Ltd.
PR-M07-22-02Jul 07, 2022
In Vitro Biology
Piramal Pharma Solutions Expands In Vitro Biology Capabilities at Ahmedabad Discovery Services Site
Piramal Pharma Solutions
PR-M01-22-03Jan 04, 2022
Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs
Piramal Pharma Solutions
PR-M03-21-008Mar 31, 2021
API Manufacturing
Piramal Pharma Solutions Invests $25 Million CAD to Expand its Aurora, Canada Facility with a State-of-the-Art API Manufacturing Wing
Piramal Pharma Ltd.
PR-M01-20-NI-038Jan 28, 2020
Collaboration
Piramal Pharma Solutions Announces Collaboration with BerGenBio on the Development of FDA Fast Track Designated Leukemia Treatment
Piramal Pharma Solutions
PR-M12-19-NI-005Dec 05, 2019
Integration
True Integration is Integral to Providing One-Stop-Shop CDMO Services
Stuart E. Needleman
Piramal Pharma Solutions
PAP-Q3-19-CL-022Oct 28, 2019
Launch
Piramal Announces the Launch of Cinacalcet by its Partner, Slate Run Pharmaceuticals, in the U.S.
Piramal Pharma Ltd.
PR-M03-19-NI-034Mar 13, 2019
Antibody-Drug Conjugates
Rapid Growth in the ADC Market Drives Strategic Partnership Interest
Allan Davidson
Piramal Pharma Solutions
PAP-Q1-2019-CL-031Mar 12, 2019
Award
Piramal Pharma Solutions Wins in Six Categories at the 'CMO Leadership Awards 2018'
Piramal Pharma Solutions
PR-M03-18-NI-099Mar 28, 2018